Modeling the Cost Savings of Continuous Pulse Oximetry and Capnography Monitoring of United States General Care Floor Patients Receiving Opioids Based on the PRODIGY Trial
Ashish K Khanna, Carla R Jungquist, Wolfgang Buhre, Roy Soto, Fabio Di Piazza, Leif Saager, PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) Group Investigators, Sergio D Bergese, Hiroshi Morimatsu, Shoichi Uezono, Simon Lee, Lian Kah Ti, Richard D Urman, Robert McIntyre Jr, Carlos Tornero, Albert Dahan, Toby N Weingarten, Maria Wittmann, Dennis Auckley, Luca Brazzi, Morgan Le Guen, Frank Schramm, Frank J Overdyk, Ashish K Khanna, Carla R Jungquist, Wolfgang Buhre, Roy Soto, Fabio Di Piazza, Leif Saager, PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) Group Investigators, Sergio D Bergese, Hiroshi Morimatsu, Shoichi Uezono, Simon Lee, Lian Kah Ti, Richard D Urman, Robert McIntyre Jr, Carlos Tornero, Albert Dahan, Toby N Weingarten, Maria Wittmann, Dennis Auckley, Luca Brazzi, Morgan Le Guen, Frank Schramm, Frank J Overdyk
Abstract
Introduction: Despite the high incidence of respiratory depression on the general care floor and evidence that continuous monitoring improves patient outcomes, the cost-benefit of continuous pulse oximetry and capnography monitoring of general care floor patients remains unknown. This study modeled the cost and length of stay savings, investment break-even point, and likelihood of cost savings for continuous pulse oximetry and capnography monitoring of general care floor patients at risk for respiratory depression.
Methods: A decision tree model was created to compare intermittent pulse oximetry versus continuous pulse oximetry and capnography monitoring. The model utilized costs and outcomes from the PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) trial, and was applied to a modeled cohort of 2447 patients receiving opioids per median-sized United States general care floor annually.
Results: Continuous pulse oximetry and capnography monitoring of high-risk patients is projected to reduce annual hospital cost by $535,531 and cumulative patient length of stay by 103 days. A 1.5% reduction in respiratory depression would achieve a break-even investment point and justify the investment cost. The probability of cost saving is ≥ 80% if respiratory depression is decreased by ≥ 17%. Expansion of continuous monitoring to high- and intermediate-risk patients, or to all patients, is projected to reach a break-even point when respiratory depression is reduced by 2.5% and 3.5%, respectively, with a ≥ 80% probability of cost savings when respiratory depression decreases by ≥ 27% and ≥ 31%, respectively.
Conclusion: Compared to intermittent pulse oximetry, continuous pulse oximetry and capnography monitoring of general care floor patients receiving opioids has a high chance of being cost-effective.
Trial registration: www.clinicaltrials.gov , Registration ID: NCT02811302.
Keywords: Break-even analysis; Capnography; Continuous monitoring; Cost savings; Economic model; General care floor; Healthcare economics; Pulse oximetry; Respiratory compromise; Respiratory depression.
© 2021. The Author(s).
Figures
References
- Sun Z, Sessler DI, Dalton JE, et al. Postoperative hypoxemia is common and persistent: a prospective blinded observational study. Anesth Analg. 2015;121(3):709–715. doi: 10.1213/ANE.0000000000000836.
- Khanna AK, Bergese SD, Jungquist CR, et al. Prediction of opioid-induced respiratory depression on inpatient wards using continuous capnography and oximetry: an international prospective, observational trial. Anesth Analg. 2020;131(4):1012–1024. doi: 10.1213/ANE.0000000000004788.
- Gupta K, Prasad A, Nagappa M, Wong J, Abrahamyan L, Chung FF. Risk factors for opioid-induced respiratory depression and failure to rescue: a review. Curr Opin Anaesthesiol. 2018;31(1):110–119. doi: 10.1097/ACO.0000000000000541.
- Turan A, Chang C, Cohen B, et al. Incidence, severity, and detection of blood pressure perturbations after abdominal surgery: a prospective blinded observational study. Anesthesiology. 2019;130(4):550–559. doi: 10.1097/ALN.0000000000002626.
- Overdyk FJ, Carter R, Maddox RR, Callura J, Herrin AE, Henriquez C. Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia. Anesth Analg. 2007;105(2):412–418. doi: 10.1213/01.ane.0000269489.26048.63.
- Khanna AK, Saager L, Bergese SD, et al. Opioid-induced respiratory depression increases hospital costs and length of stay in patients recovering on the general care floor. BMC Anesthesiol. 2021;21(88):1.
- Lee LA, Caplan RA, Stephens LS, et al. Postoperative opioid-induced respiratory depression: a closed claims analysis. Anesthesiology. 2015;122(3):659–665. doi: 10.1097/ALN.0000000000000564.
- Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage. 2003;25(3):276–283. doi: 10.1016/S0885-3924(02)00691-7.
- Kane-Gill SL, Rubin EC, Smithburger PL, Buckley MS, Dasta JF. The cost of opioid-related adverse drug events. J Pain Palliat Care Pharmacother. 2014;28(3):282–293. doi: 10.3109/15360288.2014.938889.
- Urman RD, Seger DL, Fiskio JM, et al. The burden of opioid-related adverse drug events on hospitalized previously opioid-free surgical patients. J Patient Saf. 2021;17(2):e76–e83. doi: 10.1097/PTS.0000000000000566.
- Taenzer AH, Pyke JB, McGrath SP, Blike GT. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010;112(2):282–287. doi: 10.1097/ALN.0b013e3181ca7a9b.
- Fischer JP, Shang EK, Butler CE, et al. Validated model for predicting postoperative respiratory failure: analysis of 1706 abdominal wall reconstructions. Plast Reconstr Surg. 2013;132(5):826e–e835. doi: 10.1097/PRS.0b013e3182a4c442.
- Cozowicz C, Olson A, Poeran J, et al. Opioid prescription levels and postoperative outcomes in orthopedic surgery. Pain. 2017;158(12):2422–2430. doi: 10.1097/j.pain.0000000000001047.
- Dunwoody D, Jungquist CR. Monitoring for opioid-induced advancing sedation and respiratory depression: ASPMN membership survey of current practice 2019. 2019 ASPMN Annual Conference, Portland, Oregon. 2019.
- Jungquist CR, Quinlan-Colwell A, Vallerand A, et al. American Society for Pain Management nursing guidelines on monitoring for opioid-induced advancing sedation and respiratory depression: revisions. Pain Manag Nurs. 2020;21(1):7–25. doi: 10.1016/j.pmn.2019.06.007.
- Stites M, Surprise J, McNiel J, Northrop D, De Ruyter M. Continuous capnography reduces the incidence of opioid-induced respiratory rescue by hospital rapid resuscitation team. J Patient Saf. 2017. 10.1097/PTS.0000000000000408.
- Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS)–explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–250. doi: 10.1016/j.jval.2013.02.002.
- Khanna AK, Overdyk FJ, Greening C, Di Stefano P, Buhre WF. Respiratory depression in low acuity hospital settings—seeking answers from the PRODIGY trial. J Crit Care. 2018;47:80–87. doi: 10.1016/j.jcrc.2018.06.014.
- Overdyk FJ, Dowling O, Marino J, et al. Association of opioids and sedatives with increased risk of in-hospital cardiopulmonary arrest from an administrative database. PLoS One. 2016;11(2):e0150214. doi: 10.1371/journal.pone.0150214.
- Herzig SJ, Rothberg MB, Cheung M, Ngo LH, Marcantonio ER. Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals. J Hosp Med. 2014;9(2):73–81. doi: 10.1002/jhm.2102.
- Shafi S, Collinsworth AW, Copeland LA, et al. Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system. JAMA Surg. 2018;153(8):757–763. doi: 10.1001/jamasurg.2018.1039.
- Donohue JM, Kennedy JN, Seymour CW, et al. Patterns of opioid administration among opioid-naive inpatients and associations with postdischarge opioid use: a cohort study. Ann Intern Med. 2019;171(2):81–90. doi: 10.7326/M18-2864.
- Niroula A, Garvia V, Rives-Sanchez M, et al. Opiate use and escalation of care in hospitalized adults with acute heart failure and sleep-disordered breathing (OpiatesHF study) Ann Am Thorac Soc. 2019;16(9):1165–1170. doi: 10.1513/AnnalsATS.201902-100OC.
- Lam T, Nagappa M, Wong J, Singh M, Wong D, Chung F. Continuous pulse oximetry and capnography monitoring for postoperative respiratory depression and adverse events: a systematic review and meta-analysis. Anesth Analg. 2017;125(6):2019–2029. doi: 10.1213/ANE.0000000000002557.
- Steele T, Eidem L, Bond J. Impact of adoption of smart pump system with continuous capnography monitoring on opioid-related adverse event rates: experience from a tertiary care hospital. J Patient Saf. 2019;16:e194. doi: 10.1097/PTS.0000000000000584.
- Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: OUP; 2006.
- Oderda GM, Gan TJ, Johnson BH, Robinson SB. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother. 2013;27(1):62–70. doi: 10.3109/15360288.2012.751956.
- Kessler ER, Shah M, Gurschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013;33(4):383–391. doi: 10.1002/phar.1223.
- McCarter T, Shaik Z, Scarfo K, Thompson LJ. Capnography monitoring enhances safety of postoperative patient-controlled analgesia. Am Health Drug Benefits. 2008;1(5):28–35.
- Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644–1656. doi: 10.1016/S0140-6736(16)00161-6.
- Burden M, Keniston A, Wallace MA, et al. Opioid utilization and perception of pain control in hospitalized patients: a cross-sectional study of 11 sites in 8 countries. J Hosp Med. 2019;14(12):737–745. doi: 10.12788/jhm.3256.
- Ladha KS, Neuman MD, Broms G, et al. Opioid prescribing after surgery in the United States, Canada, and Sweden. JAMA Netw Open. 2019;2(9):e1910734. doi: 10.1001/jamanetworkopen.2019.10734.
- Papanicolas I, Woskie LR, Jha AK. Health care spending in the united states and other high-income countries. JAMA. 2018;319(10):1024–1039. doi: 10.1001/jama.2018.1150.
Source: PubMed